Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
97 Results for "
inactive control
" in MedChemExpress (MCE) Product Catalog:
Products (97)
97 Results for "inactive control" in MCE Product Catalog:
Cat. No.: HY-145514B
Target:
Research Areas:
dTAGV-1-NEG TFA is an inactive FKBP12 F36V PROTAC degrader, the diastereomer of dTAGV-1 (HY-145514D), and a heterobifunctional negative control molecule. dTAGV-1-NEG TFA does not degrade any protein .
Cat. No.: HY-170859A
Target:
Research Areas:
AH081 is a CK1δ/ε PROTAC degrader. AH081 serves as the negative control of AH078 (HY-170859). AH081 exhibits inhibitory activity but no degradative activity against CK1δ/ε by using an inactive stereoisomer of the VHL ligand .
Cat. No.: HY-118914
CAS No.: 362482-00-6
Target:
Glucagon receptor antagonist inactive control (Compound 2) is a compound structurally similar to the glucagon receptor (GCGR) antagonist Glucagon receptor antagonist (Compound 1) but lacks antagonistic activity against glucagon receptor (GCGR). Glucagon receptor antagonist inactive control can be used as a negative control to study mechanisms related to glucagon receptor-mediated signaling pathways .
Cat. No.: HY-112306R
CAS No.: 1442472-39-0
Synonyms: DCC-2618 (Standard)
Ripretinib (Standard) is the analytical standard of Ripretinib. This product is intended for research and analytical applications. Ripretinib (DCC-2618) is an orally bioavailable, selective KIT and PDGFRA switch-control inhibitor. Ripretinib (DCC-2618) targets and binds to both wild-type and mutant forms of KIT and PDGFRA specifically at their switch pocket binding sites, thereby preventing the switch from inactive to active conformations of these kinases and inactivating their wild-type and mutant forms. Ripretinib (DCC-2618) also inhibits multiple other kinase targets, such as FLT3 and KDR (or VEGFR-2) . DCC-2618 exerts antineoplastic effect and induces apoptosis .
Cat. No.: HY-113894
CAS No.: 1028332-91-3
Target:
Research Areas:
Retreversine is an inactive control for Reversine. Reversine is a novel class of ATP-competitive Aurora kinase inhibitor .
Target:
Research Areas:
CR-1-30-B is an inactive enantiomer of CR-1-31-B. CR-1-30-B, as a control, is inactive against eIF4A and has no apparent effect on the induction of MUC1-C translation .
Cat. No.: HY-P3970C
CAS No.: 162290-88-2
Target:
Research Areas:
Cat. No.: HY-101125B
CAS No.: 2084850-77-9
Synonyms: D-45
Target:
Research Areas:
D-Moses (D-45) is an enantiomer of L-Moses (HY-101125). L-Moses (L-45) is a potent and selective p300/CBP-associated factor (PCAF) bromodomain (Brd) inhibitor. D-Moses shows no observable binding for PCAF Brd. D-Moses can be used as an inactive control compound to L-Moses .
Cat. No.: HY-119857
CAS No.: 304896-21-7
Synonyms: SIRT2 Inhibitor,inactive control
Target:
Research Areas:
AGK7 is a potent inhibitor of sirtuin 2 (SIRT2). AGK7 rescues alpha-synuclein toxicity and modified inclusion morphology in a cellular model of Parkinson's disease. AGK7 protects against dopaminergic cell death both in vitro and in a Drosophila model of Parkinson's disease .
Cat. No.: HY-P1849
CAS No.: 402941-23-5
Synonyms: scJag-1
Target:
Research Areas:
Cat. No.: HY-126300A
CAS No.: 2561471-15-4
Target:
Research Areas:
SGC6870N is inactive against PRMT6 and can be utilized as a negative control. SGC6870N is an inactive enantiomer of SGC6870 (HY-126300) .
Cat. No.: HY-P2248
CAS No.: 1885873-44-8
Target:
Research Areas:
Cat. No.: HY-P1312
CAS No.: 245329-01-5
Research Areas:
Cat. No.: HY-P1312A
Research Areas:
Cat. No.: HY-155221
CAS No.: 2561494-78-6
Target:
Research Areas:
UNC7145 is an inactive derivative of UNC6934 (HY-145103) that can be used as a negative control for the protein-protein inhibition activity of UNC6934.
Cat. No.: HY-P2250
Synonyms: ELA-32 negative control
Target:
Research Areas:
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
